Iron homoeostasis in rheumatic disease
Authors:
Open Access
- 23 July 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 48 (11) , 1339-1344
Abstract
Iron is critical in nearly all cell functions and the ability of a cell, tissue and organism to procure this metal is obligatory for survival. Iron is necessary for normal immune function, and relative iron deficiency is associated with mild immunosuppression. Concentrations of this metal in excess of those required for function can present both an oxidative stress and elevate risks for infection. As a result, the human has evolved to have a complex mechanism of regulating iron and limiting its availability. This homoeostasis can be disrupted. Autoimmune diseases and gout often present with abnormal iron homoeostasis, thus supporting a participation of the metal in these injuries. We review the role of iron in normal immune function and discuss both clinical evidence of altered iron homoeostasis in autoimmune diseases and gout as well as possible implications of both depletion and supplementation of this metal in this patient population. We conclude that altered iron homoeostasis may represent a purposeful response to inflammation that could have theoretical anti-inflammatory benefits. We encourage physicians to avoid routine iron supplementation in those without depleted iron stores.Keywords
This publication has 55 references indexed in Scilit:
- Constitutive expression of Bcl-2 in the haematopoietic compartment alters the metabolism of iron and increases resistance to mycobacterial infectionClinical and Experimental Immunology, 2009
- Hepcidin: from discovery to differential diagnosisHaematologica, 2008
- Orchestration of Iron HomeostasisNew England Journal of Medicine, 2005
- The effect of iron deficiency anemia on the function of the immune systemThe Hematology Journal, 2005
- High iron stores and ischemic heart disease in rheumatoid arthritis and systemic Lupus ErythematosusThe American Journal of Cardiology, 2004
- Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial.Annals of the Rheumatic Diseases, 1996
- Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritisRheumatology International, 1996
- Iron-binding proteins and free iron in synovial fluids of rheumatoid arthritis patientsClinical Rheumatology, 1989
- Collagen arthritis in the rat is initiated by CD4+ T cells and can be amplified by ironCellular Immunology, 1989
- The adverse effect of iron repletion on the course of certain infections.BMJ, 1978